DATE16 Jul

NIFTY 24,073 ▼ 0.02%BANK NIFTY 57,582 ▼ 0.30%NIFTY IT 28,723 ▲ 0.67%NIFTY PHARMA 26,008 ▲ 0.02%ICICIGI 1,624 ▼ 10.51%MRPL 173 ▲ 10.07%EMMVEE 365 ▲ 8.16%CHENNPETRO 1,241 ▲ 7.22%ABB 7,668 ▲ 6.43%DIXON 14,507 ▲ 6.27%HSCL 722 ▲ 5.99%SIGNATURE 793 ▼ 5.77%NUVOCO 358 ▼ 5.12%ITCHOTELS 174 ▼ 5.11%NIFTY 24,073 ▼ 0.02%BANK NIFTY 57,582 ▼ 0.30%NIFTY IT 28,723 ▲ 0.67%NIFTY PHARMA 26,008 ▲ 0.02%ICICIGI 1,624 ▼ 10.51%MRPL 173 ▲ 10.07%EMMVEE 365 ▲ 8.16%CHENNPETRO 1,241 ▲ 7.22%ABB 7,668 ▲ 6.43%DIXON 14,507 ▲ 6.27%HSCL 722 ▲ 5.99%SIGNATURE 793 ▼ 5.77%NUVOCO 358 ▼ 5.12%ITCHOTELS 174 ▼ 5.11%

Morning brief · Friday, 17 July 2026

JNK India’s ₹200 crore fumble rattles its 70% rally

Market pulse

Indian markets ended the week on a flat note as weakness in banking stocks, which pulled the Bank Nifty down, was offset by a strong showing from the IT sector. While ICICI Lombard General Insurance saw a sharp drop of over ten percent, refinery stocks like MRPL and Chennai Petroleum rallied significantly.

From the investor's mind

One post worth your time, explained

@ShashankUdupa1 · on X

India is embarking on a significant fertilizer investment cycle, as the government has sanctioned a policy aimed at expanding urea production capacity by 10 million tonnes (MnTn). This initiative offers a guaranteed 12-16% Return on Equity (ROE) for qualifying projects, creating a favorable environment for companies such as Chambal Fertilisers, RCF, National Fertilisers, and Coromandel. Shashank Udupa highlights this as a key development, signaling potential growth for these firms within the fertilizer sector.

Word in the street

What the wider market is buzzing about

JNK India Limited

₹546Past year ▲ 70%M.cap ₹2,824 Cr

JNK India has been a strong performer, rising over 70 percent in the last year, but a recent development has caught the market’s attention. The company, with a market capitalisation of about 2,824 crore, announced the cancellation of a roughly 200 crore order from an ADNOC project. The order was lost because JNK India did not secure a mandatory approval from the project's technology licensor. While the company stated this would have no impact on declared revenue or profits, some investors are questioning the potential effect on future projections for the current financial year, wondering if it alters the outlook for the company.

Know more about the stock

Yesterday's big moves